These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2058482)

  • 1. MR imaging of phenylketonuria.
    Shaw DW; Maravilla KR; Weinberger E; Garretson J; Trahms CM; Scott CR
    AJNR Am J Neuroradiol; 1991; 12(3):403-6. PubMed ID: 2058482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenylketonuria: white-matter changes assessed by 3.0-T magnetic resonance (MR) imaging, MR spectroscopy and MR diffusion.
    Scarabino T; Popolizio T; Tosetti M; Montanaro D; Giannatempo GM; Terlizzi R; Pollice S; Maiorana A; Maggialetti N; Carriero A; Leuzzi V; Salvolini U
    Radiol Med; 2009 Apr; 114(3):461-74. PubMed ID: 19277839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter.
    Kono K; Okano Y; Nakayama K; Hase Y; Minamikawa S; Ozawa N; Yokote H; Inoue Y
    Radiology; 2005 Aug; 236(2):630-6. PubMed ID: 16040919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings.
    Bick U; Ullrich K; Stöber U; Möller H; Schuierer G; Ludolph AC; Oberwittler C; Weglage J; Wendel U
    Eur J Pediatr; 1993 Dec; 152(12):1012-20. PubMed ID: 8131802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change.
    Cleary MA; Walter JH; Wraith JE; White F; Tyler K; Jenkins JP
    J Pediatr; 1995 Aug; 127(2):251-5. PubMed ID: 7636650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted imaging of white matter abnormalities in patients with phenylketonuria.
    Phillips MD; McGraw P; Lowe MJ; Mathews VP; Hainline BE
    AJNR Am J Neuroradiol; 2001 Sep; 22(8):1583-6. PubMed ID: 11559511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Brain white matter lesions of children with phenylketonuria before and after treatment].
    Wang ZX; Zhou ZS; Yu WM
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Feb; 8(1):13-6. PubMed ID: 16522231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Magnetic resonance imaging of the brain in phenylketonuria].
    Izumi M; Yamazaki H; Nakabayashi H; Owada M
    No To Hattatsu; 2006 Jan; 38(1):27-31. PubMed ID: 16447793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment.
    Pietz J; Kreis R; Schmidt H; Meyding-Lamadé UK; Rupp A; Boesch C
    Radiology; 1996 Nov; 201(2):413-20. PubMed ID: 8888233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylketonuria: MR imaging of the brain with clinical correlation.
    Pearsen KD; Gean-Marton AD; Levy HL; Davis KR
    Radiology; 1990 Nov; 177(2):437-40. PubMed ID: 2217781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging of the brain in phenylketonuria.
    Cleary MA; Walter JH; Wraith JE; Jenkins JP; Alani SM; Tyler K; Whittle D
    Lancet; 1994 Jul; 344(8915):87-90. PubMed ID: 7912392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain CT and MR findings in hyperphenylalaninemia due to dihydropteridine reductase deficiency (variant of phenylketonuria).
    Sugita R; Takahashi S; Ishii K; Matsumoto K; Ishibashi T; Sakamoto K; Narisawa K
    J Comput Assist Tomogr; 1990; 14(5):699-703. PubMed ID: 2398144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological deterioration in adult phenylketonuria.
    Villasana D; Butler IJ; Williams JC; Roongta SM
    J Inherit Metab Dis; 1989; 12(4):451-7. PubMed ID: 2516176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cranial MR in phenylketonuria.
    Shaw DW; Weinberger E; Maravilla KR
    J Comput Assist Tomogr; 1990; 14(3):458-60. PubMed ID: 2335616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spasticity and white matter abnormalities in adult phenylketonuria.
    McCombe PA; McLaughlin DB; Chalk JB; Brown NN; McGill JJ; Pender MP
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):359-61. PubMed ID: 1602307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of cerebral white matter abnormalities in early treated patients with phenylketonuria during adolescence.
    Weglage J; Bick U; Schuierer G; Pietsch M; Sprinz A; Zass R; Ullrich K
    Neuropediatrics; 1997 Aug; 28(4):239-40. PubMed ID: 9309716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A neurological evaluation of adult phenylketonuria in Northern Ireland.
    McDonnell GV; Esmonde TF; Hadden DR; Morrow JI
    Eur Neurol; 1998; 39(1):38-43. PubMed ID: 9476722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter pathology in phenylketonuria.
    Anderson PJ; Leuzzi V
    Mol Genet Metab; 2010; 99 Suppl 1():S3-9. PubMed ID: 20123467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging of the brain in adolescents with phenylketonuria and in one case of 6-pyruvoyl tetrahydropteridine synthase deficiency.
    Pietz J; Meyding-Lamadé UK; Schmidt H
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S69-73. PubMed ID: 8828614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria.
    Leuzzi V; Bianchi MC; Tosetti M; Carducci CL; Carducci CA; Antonozzi I
    J Inherit Metab Dis; 2000 Sep; 23(6):563-70. PubMed ID: 11032331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.